RedPath IP Raises Series A

RedPath Integrated Pathology Inc., a Pittsburgh-based cancer diagnostics company, has raised $6.5 million in Series A funding. Backers include Seneca Health Partners, Inflexion Partners, HMA Capital Partners New Spring Capital and CID Capital. HealthCare Capital Advisors served as placement agent. www.redpathip.com